Unnamed stage
$63m
Queensland biotech startup Inflazome raises $63 million to change the way we treat Alzheimer’s
Queensland biotech firm Inflazome has secured a large funding round led by Forbian to advance its anti-inflammatory drug candidates into clinical trials, and has hired a chief medical officer to lead that development.
Also SmartCompany